Acquired psychiatric disorder — all decisions

The Board granted reconsideration of the issues of entitlement to service connection for basal cell carcinoma, an acquired psychiatric disorder, and bilateral upper and lower extremity diabetic peripheral neuropathy. The claims for these conditions were previously denied but are now being readjudicated due to new evidence.

The Board granted service connection for an acquired psychiatric disorder other than PTSD, but denied service connection for bilateral hearing loss and obstructive sleep apnea.

The appeal for service connection for an acquired psychiatric condition, sleep disability, special monthly compensation based on aid and attendance, housebound, and TDIU is dismissed due to the Veteran's death during the pendency of the appeal.

The Board granted service connection for an acquired psychiatric disorder, to include generalized anxiety disorder and depression, resolving reasonable doubt in the Veteran's favor.

The Board remands the claims for an acquired psychiatric disorder and rhabdomyolysis due to pre-decisional duty to assist errors, requiring additional medical opinions.

The appeal for service connection for hypertension is dismissed as the claim has been fully granted. The claims for bilateral hearing loss, back disability, fatigue, and acquired psychiatric disability are remanded for further development.

The Board denied service connection for fibromyalgia and an acquired psychiatric disorder other than the service-connected unspecified anxiety disorder, to include depression.

The Board granted service connection for bilateral knee condition and acquired psychiatric disorder, to include adjustment disorder with mixed anxiety and depression, resolving reasonable doubt in the Veteran's favor.

The appeal for service connection for an acquired psychiatric disorder is dismissed without prejudice as the benefit sought has been granted in a separate appeal.

The Board granted an earlier effective date of March 22, 2023, for service connection for obstructive sleep apnea and an acquired psychiatric condition.

The Board remands the Veteran's claim for service connection for an acquired psychiatric disorder due to an inadequate VA examination.

The Board granted service connection for an acquired psychiatric disorder, diagnosed as unspecified depressive disorder, unspecified anxiety disorder, and dysthymic disorder, and obstructive sleep apnea based on the evidence being at least evenly balanced.

The Board denied the Veteran's claims for service connection for an acquired psychiatric disorder, to include PTSD, and for earlier effective dates for a total disability rating based on individual unemployability (TDIU) and basic eligibility to Dependents' Educational Assistance (DEA).

The Board granted an initial disability rating of 70 percent for the Veteran's acquired psychiatric disorder and a total disability rating due to individual unemployability (TDIU) effective October 12, 2023.

The Board remands the Veteran's claim for service connection for an acquired psychiatric disorder, to include PTSD, due to inadequate medical opinions and a Stegall violation.

The Board remands the claims for service connection for an acquired psychiatric disorder, a stomach disorder, HTN, and a heart condition due to the need for additional evidence.

The Board remands the claims for service connection for an acquired psychiatric disorder and a compensable rating for sinusitis to obtain additional evidence.

The Board granted an earlier effective date of April 16, 2012 for the grant of service connection for an acquired psychiatric disorder, to include PTSD.

The Board denied service connection for a left inferior parietal scalp abscess and remanded the issue of an acquired psychiatric disorder.

The Board granted service connection for bilateral tinnitus, a cervical strain as secondary to a right shoulder disability on a causation basis, and an acquired psychiatric disorder (PTSD, anxiety, adjustment disorder) due to military sexual trauma (MST), while denying service connection for rhinitis, chronic sinusitis, CFS, and a neurological disorder with night sweats.